Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
24m
Stock indexes drift to end of record-setting week
All told, the S&P 500 slipped 7.20 points to 5,738.17, but it still closed out a third straight winning week and its sixth in ...
23m
For those who are an only child, no one shares the load when Mum and Dad get sick
SINGAPORE: On a Tuesday afternoon at a coffee shop in Ang Mo Kio, Glenn Poh returns to his waiting mother with two drinks: ...
Daily
18m
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Troops to leave some bases
Promotes watch collection
ICE: Convicts roaming free
Dow closes at record high
Bill to use birth control
Boxes to distribute Narcan
Producing doc on Diddy
ISR targets Hezbollah HQ
NC dam failure ‘imminent’
Urgent safety alert for 737s
KY sues Express Scripts
50/50 ball ownership suit
Killer gets life sentence
Fake Biden robocalls fine
Diocese reaches settlement
Van Gogh paintings attacked
Pleads not guilty
Congressional Gold Medal
Fed inflation gauge cools
Ending password-sharing
US charges three Iranians
NY ballot appeal rejected
Meta hit with privacy fine
World's oldest cheese found
Deposition in AI suit
Related topics
Food and Drug Administration
FDA
KarXT
Cobenfy
Bristol Myers Squibb
Feedback